Navigation Links
PDHI Launches ConXus Profile Third-Party Health Risk Assessment Data-Load Process
Date:6/23/2009

BERNARDSVILLE, N.J., June 23 /PRNewswire/ -- Protocol Driven Healthcare, Inc. (PDHI) launches the ConXus Profile Third-Party Health Risk Assessment (HRA) Data-Load Process so that organizations can merge historical data from third-party HRAs with data collected from the ConXus Profile HRA.

Organizations may be reluctant to switch their current HRA data to a new vendor for fear of losing valuable health information accumulated over time. PDHI has developed a solution in its ConXus Profile Third-Party HRA Data-Load Process. This new service enables organizations to take advantage of the data-management capability of the ConXus Platform while retaining historical HRA data.

Once third-party HRA data is loaded into the ConXus Platform, an organization can compare it with current data from ConXus Profile to provide:

  • Coach access to longitudinal HRA data for individual participants.
  • Administrator access to consolidated aggregate HRA data for outcome reporting.
  • Participant access to previous and current HRA results within the member report summary table for progress tracking.

One of the first companies to take advantage of this capability was Innovative Wellness Solutions, a client of PDHI. "Organizations are reluctant to change HRA vendors, as they do not want to lose their investment in the historical HRA data," said Stuart Sutley, chief executive officer of Innovative Wellness Solutions. "New clients can now adopt the ConXus Profile health risk assessment and take advantage of our other services that are supported on the integrated ConXus Platform. Centralizing all the program data makes it easy to track participation and measure program outcomes."

The PDHI ConXus Platform supports the delivery of private-labeled health improvement programs. Application modules include an HRA, online wellness programs, personal health record, and health-coaching tools. Application modules are delivered with the Program Center, which guides participants to required actions and key dates, a secure message center, and incentive tracking and fulfillment. Modules can be deployed in multiple configurations to match client service levels, with additional localization for each end client.

The ConXus Platform centralizes all program data, facilitating the tracking of program participation, return on investment, and changes in health status.

About Protocol Driven Healthcare, Inc.

PDHI is a healthcare technology and data processing organization that provides preventive health applications and services using the ConXus(R) health-improvement platform. For more information, visit http://www.pdhi.com/.

Recent News

PDHI --PDHI Adds Diabetes and Heart Disease Prevention to ConXus Steps Library of Action Plans

http://www.pdhi.com/webnew/corporate/pressreleases/Diabetes.asp

PDHI - PDHI's Health Risk Appraisal and Consumer Health Tools Awarded NCQA HIP Certification

http://www.pdhi.com/webnew/corporate/pressreleases/NCQA.asp

    Contact:
    David Abel
    Vice President of Sales and Marketing
    908-315-0365, ext. 1026
    davida@pdhi.com

'/>"/>
SOURCE Protocol Driven Healthcare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored ... satisfaction survey, earning them second place for Tampa’s Best Places to Work. They were ... “This is a great accomplishment for our team,” says RMS Human Resources Manager Irene ...
(Date:4/29/2016)... ... , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor Global Food ... by Hilton Hotel in Oak Brook, Illinois. The two-day event is the largest conference ... , At the seminar, IDF™ will offer samples of its Savory Bone Broth ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... clinic data for 2014. Each year, reproductive endocrinologists are required to report ... the main organization of professionals dedicated to the practice of assisted reproductive technologies ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... providers, recently announced that their founders, Dr. Gemmi and Dr. Middleberg, were asked ... 550 orthodontists around the nation. During the seminar, titled “Advancing the Biomechanics ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... April 27, 2016 Elekta today ... platform will be the focal point of seven scientific ... European Society for Radiotherapy & Oncology, taking place April ... a state-of-the-art radiotherapy system and a high-field MRI scanner ... see the patient,s anatomy in real time. The MR-linac ...
(Date:4/27/2016)... Massachusetts , April 27, 2016 ... that Jeff Poulton , Chief Financial Officer, will present ... Boston, MA on Wednesday, May 04, ... audio webcast will be available on the Presentations and Webcasts ... a replay of the webcast will be available on this ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
Breaking Medicine Technology: